Literature DB >> 8709289

A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4.

D E Brough1, A Lizonova, C Hsu, V A Kulesa, I Kovesdi.   

Abstract

The improvements to adenovirus necessary for an optimal gene transfer vector include the removal of virus gene expression in transduced cells, increased transgene capacity, complete replication incompetence, and elimination of replication-competent virus that can be produced during the growth of first-generation adenovirus vectors. To achieve these aims, we have developed a vector-cell line system for complete functional complementation of both adenovirus early region 1 (E1) and E4. A library of cell lines that efficiently complement both E1 and E4 was constructed by transforming 293 cells with an inducible E4-ORF6 expression cassette. These 293-ORF6 cell lines were used to construct and propagate viruses with E1 and E4 deleted. While the construction and propagation of AdRSV beta gal.11 (an E1-/E4- vector engineered to contain a deletion of the entire E4 coding region) were possible in 293-ORF6 cells, the yield of purified virus was depressed approximately 30-fold compared with that of E1- vectors. The debilitation in AdRSV beta gal.11 vector growth was found to correlate with reduced fiber protein and mRNA accumulation. AdCFTR.11A, a modified E1-/E4- vector with a spacer sequence placed between late region 5 and the right inverted terminal repeat, efficiently expressed fiber and grew with the same kinetic profile and virus yield as did E1- vectors. Moreover, purified AdCFTR.11A yields were equivalent to E1- vector levels. Since no overlapping sequences exist in the E4 regions of E1-/E4- vectors and 293-ORF6 cell lines, replication-competent virus cannot be generated by homologous recombination. In addition, these second-generation E1-/E4- vectors have increased transgene capacity and have been rendered virus replication incompetent outside of the new complementing cell lines.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709289      PMCID: PMC190687          DOI: 10.1128/JVI.70.9.6497-6501.1996

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  mRNAs from human adenovirus 2 early region 4.

Authors:  A Virtanen; P Gilardi; A Näslund; J M LeMoullec; U Pettersson; M Perricaudet
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

2.  Splice junctions in adenovirus 2 early region 4 mRNAs: multiple splice sites produce 18 to 24 RNAs.

Authors:  M A Tigges; H J Raskas
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

3.  Altered mRNA splicing in monkey cells abortively infected with human adenovirus may be responsible for inefficient synthesis of the virion fiber polypeptide.

Authors:  K P Anderson; D F Klessig
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

4.  Isolation of a variant of human adenovirus serotype 2 that multiplies efficiently on monkey cells.

Authors:  D F Klessig
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

5.  Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff.

Authors:  D N Halbert; J R Cutt; T Shenk
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

6.  Characterization of the major mRNAs from adenovirus 2 early region 4 by cDNA cloning and sequencing.

Authors:  G A Freyer; Y Katoh; R J Roberts
Journal:  Nucleic Acids Res       Date:  1984-04-25       Impact factor: 16.971

7.  The function(s) provided by the adenovirus-specified, DNA-binding protein required for viral late gene expression is independent of the role of the protein in viral DNA replication.

Authors:  S A Rice; D F Klessig
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

8.  Introduction, stable integration, and controlled expression of a chimeric adenovirus gene whose product is toxic to the recipient human cell.

Authors:  D F Klessig; D E Brough; V Cleghon
Journal:  Mol Cell Biol       Date:  1984-07       Impact factor: 4.272

9.  A cascade of adenovirus early functions is required for expression of adeno-associated virus.

Authors:  W D Richardson; H Westphal
Journal:  Cell       Date:  1981-11       Impact factor: 41.582

10.  Adenovirus E4-dependent activation of the early E2 promoter is insufficient to promote the early-to-late-phase transition.

Authors:  C Hemström; A Virtanen; E Bridge; G Ketner; U Pettersson
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more
  49 in total

1.  Induction of endogenous genes following infection of human endothelial cells with an E1(-) E4(+) adenovirus gene transfer vector.

Authors:  R Ramalingam; S Rafii; S Worgall; N R Hackett; R G Crystal
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication.

Authors:  J E Nelson; M A Kay
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Construction of an adenovirus type 7a E1A- vector.

Authors:  K Abrahamsen; H L Kong; A Mastrangeli; D Brough; A Lizonova; R G Crystal; E Falck-Pedersen
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41.

Authors:  Franck Lemiale; Hedi Haddada; Gary J Nabel; Douglas E Brough; C Richter King; Jason G D Gall
Journal:  Vaccine       Date:  2006-11-28       Impact factor: 3.641

5.  Expression of gp19K increases the persistence of transgene expression from an adenovirus vector in the mouse lung and liver.

Authors:  J T Bruder; T Jie; D L McVey; I Kovesdi
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  High-efficiency transfer and expression of AdCMV-p53 in human cervix adenocarcinoma cells induced by subclinical-dose carbon beam radiation.

Authors:  Bing Liu; Hong Zhang; Xiaohong Luo; Yi Xie; Jifang Hao; Qingming Zhou; Xin Duan; Yanling Wang; Weiping Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2008-12-16       Impact factor: 4.553

7.  Replication-defective adenovirus vectors with multiple deletions do not induce measurable vector-specific T cells in human trials.

Authors:  Richard A Koup; Laurie Lamoreaux; David Zarkowsky; Robert T Bailer; C Richter King; Jason G D Gall; Douglas E Brough; Barney S Graham; Mario Roederer
Journal:  J Virol       Date:  2009-04-01       Impact factor: 5.103

8.  Identification of a suppressor mutation that improves the yields of hexon-modified adenovirus vectors.

Authors:  Joseph T Bruder; Ping Chen; Elena Semenova; Charlie A Thomas; Svetlana Konovalova; Greg Ekberg; Damodar Ettyreddy; Duncan McVey; Jason G Gall; C Richter King; Douglas E Brough
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

9.  Unique cellular and humoral immunogenicity profiles generated by aerosol, intranasal, or parenteral vaccination in rhesus macaques.

Authors:  Diane L Bolton; Kaimei Song; Georgia D Tomaras; Srinivas Rao; Mario Roederer
Journal:  Vaccine       Date:  2016-12-29       Impact factor: 3.641

10.  Type I interferon-dependent activation of NK cells by rAd28 or rAd35, but not rAd5, leads to loss of vector-insert expression.

Authors:  Matthew J Johnson; Niklas K Björkström; Constantinos Petrovas; Frank Liang; Jason G D Gall; Karin Loré; Richard A Koup
Journal:  Vaccine       Date:  2013-12-08       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.